Total Versus Subtotal Abdominal Hysterectomy at Time of Abdominal Sacrocolpopexy

Sponsor
South Valley University (Other)
Overall Status
Completed
CT.gov ID
NCT04178473
Collaborator
(none)
70
1
2
28.9
2.4

Study Details

Study Description

Brief Summary

Uterovaginal prolapse is a common disease. Due to high failure rate that occur following vaginal hysterectomy, sacrocolpopexy is investigated by many resarchers to manage uterovaginal prolapse in non-hystrectomized women.

In this study the investigator will compare the result of total versus subtotal hysterectomy at the time of sacrocolpopexy.

Study design: Randomized controlled trial

Intervention:

Group A will have total abdominal hysterectomy Group B will have subtotal abdominal hysterectomy

Condition or Disease Intervention/Treatment Phase
  • Procedure: total abdominal hysterectomy
  • Procedure: Subtotal abdominal hysterectomy
N/A

Detailed Description

Uterovaginal prolapse is a common disease. Sacrocolpopexy is essentially invented to manage prolapse of the vault following hysterectomy. Due to high failure rate that occur following vaginal hysterectomy, sacrocolpopexy is investigated by many resarchers to manage uterovaginal prolapse in non-hystrectomized women. The main drawback of sacrocolpopexy is the risk of mesh erosion. The incidence of mesh erosion is 0-5% at follow up of 1 year and 0.5% at follow up of 7 years. After total hysterectomy, the mesh is sutured to the vaginal wall using non-absorbable sutures. Sutures that span the whole thickness of vaginal and involve the vaginal skin was considered the probable factor that result in mesh erosion. After subtotal hysterectomy, the mesh is fixed to the anterior and the posterior cervical surfaces. The cervix has thick wall and the risk associated with "deep" stiches does not exist.

In this study the investigator will compare the result of total versus subtotal hysterectomy at the time of sacrocolpopexy.

Patients and methods

Study design:

Randomized controlled trial

Patients:

Data will be collected from the patients admitted to the obstetrics and gynecology department, Qen faculty of medicine, South Valley University, Egypt from the 1st of January 2019 until 30th of December 2019. Follow up data will be collected until 30th of December 2020. Written consent will be obtained at time of recruitment. The Inclusion criteria are nonhystrectomized patients who will undergo sacrocolpopexy. Exclusion criteria were (1) women age less than 40; (2) desire to retain the uterus; (3) women who are unfit for lengthy surgery. Randomization will be through closed envelop method.

Intervention Group A will have total abdominal hysterectomy Group B will have subtotal abdominal hysterectomy Sacrocolpopexy will be done using Polypropylene mesh. Both groups will be done by the same surgeon using the following technique: dissection of the vesicovaginal and the rectovaginal spaces to prepare for the site of mesh placement. Dissection will be continued in the rectovaginal septum using sharp and blunt dissection until reaching the level of the levator ani (the length of the posterior vaginal mesh arm is nearly equal to the total vaginal length). The limit of the dissection in the vesicovaginal plane is down to the bladder neck (known by palpation of the Foley's catheter balloon) after lateralization of the ureters. The mesh is sutured to the anterior and the posterior vaginal wall the mesh using non-absorbable sutures. In women with subtotal hysterectomy, the mesh will be also sutured to the cervix. The mesh is then sutured to the anterior longitudinal ligament on the anterior surface of the fifth lumbar vertebra and the sacral promontory using non-absorbable sutures. Suturing of the peritoneum over the mesh will be done.

Outcomes:

The primary outcome will be mesh erosion. Secondary outcomes will be complications including recurrence

Study Design

Study Type:
Interventional
Actual Enrollment :
70 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Group A will have total abdominal hysterectomy Group B will have subtotal abdominal hysterectomy Sacrocolpopexy will be done using Polypropylene mesh for all women with uterovaginal prolapseGroup A will have total abdominal hysterectomy Group B will have subtotal abdominal hysterectomy Sacrocolpopexy will be done using Polypropylene mesh for all women with uterovaginal prolapse
Masking:
Triple (Participant, Care Provider, Investigator)
Masking Description:
Double (Participant, Investigator) closed envelop will be used for randomization. The patient and the investigator will be blinded.
Primary Purpose:
Prevention
Official Title:
Total Versus Subtotal Abdominal Hysterectomy at Time of Abdominal Sacrocolpopexy
Actual Study Start Date :
Jan 1, 2019
Actual Primary Completion Date :
Jan 30, 2021
Actual Study Completion Date :
May 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: total abdominal hysterectomy

Total abdominal hysterectomy at the time of sacrocolpopexy operation for uterovaginal prolapse

Procedure: total abdominal hysterectomy
total abdominal hysterectomy at time of sacrocolpopexy

Active Comparator: subtotal abdominal hysterectomy

subtotal abdominal hysterectomy at the time of sacrocolpopexy operation for uterovaginal prolapse

Procedure: Subtotal abdominal hysterectomy
Subtotal abdominal hysterectomy at time of sacrocolpopexy

Outcome Measures

Primary Outcome Measures

  1. Mesh erosion [12 months or more]

    Mesh exposure through the lumen of the vagina, bladder, or rectum

Secondary Outcome Measures

  1. recurrence [12 months or more]

    recurrence of vaginal wall prolapse or vault prolapse

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • nonhystrectomized patients who will undergo sacrocolpopexy for uterovaginal prolapse
Exclusion Criteria:
  • women age less than 40

  • desire to retain the uterus

  • women who are unfit for lengthy surgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 South Valley University, Qena Faculty of Medicine, Obstetrics and Gynecology Department Qinā Qena Egypt

Sponsors and Collaborators

  • South Valley University

Investigators

  • Principal Investigator: Mohammad AM Ahmed, MD, South Valley University, Qena Faculty of Medicine, Obstetrics and Gynecology Department, Qena, Qena, Egypt

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Mohammad Abdel-Rahman Mohammad Ahmed, Doctor, South Valley University
ClinicalTrials.gov Identifier:
NCT04178473
Other Study ID Numbers:
  • OBGYN 0101
First Posted:
Nov 26, 2019
Last Update Posted:
Sep 21, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mohammad Abdel-Rahman Mohammad Ahmed, Doctor, South Valley University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 21, 2021